WO2026120353 - OPHTHALMOLOGICAL COLLYRIUM AND/OR SUITABLE PHARMACEUTICAL VEHICLE
National phase entry is expected:
Publication Number
WO/2026/120353
Publication Date
11.06.2026
International Application No.
PCT/IB2025/058459
International Filing Date
22.08.2025
Title **
[English]
OPHTHALMOLOGICAL COLLYRIUM AND/OR SUITABLE PHARMACEUTICAL VEHICLE
[Spanish]
COLIRIO OFTALMOLÓGICO Y/O VEHÍCULO FARMACÉUTICO INDICADO
[French]
COLLYRE OPHTALMOLOGIQUE ET/OU VÉHICULE PHARMACEUTIQUE INDIQUÉ
Applicants **
ESPECIALIDADES OFTALMOLOGICAS S.A.
Inventors
ACOSTA GIL, Edgar Giovanny
Priority Data
NC2024/0016594
02.12.2024
CO
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
INAPI
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1956 | |
| EPO | Filing, Examination, Granting | 11576 | |
| Japan | Filing, Examination, Granting | 1908 | |
| South Korea | Filing, Examination, Granting | 1606 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,786
Contact Us
Abstract[English]
The present invention belongs to the field of ophthalmology, specifically the development of advanced ophthalmic collyria. This domain covers pharmaceutical formulations for treating chronic eye diseases. The developed technology combines innovative approaches in ocular tribology and tear film bioengineering, focusing on the restoration of the rheological properties of the tear film to improve the lubrication, stability and health of the eye surface. In addition, the invention falls within the sphere of controlled-release ophthalmic formulations, with technologies that optimise surface tension, osmolarity and viscosity, providing a more effective and longer lasting therapeutic solution.[Spanish]
La presente invención se enmarca en el sector de la oftalmología, específicamente en el desarrollo de colirios oftálmicos avanzados. Este campo abarca formulaciones farmacéuticas destinadas al tratamiento de enfermedades oculares crónicas. La tecnología desarrollada combina enfoques innovadores en la tribología ocular y la bioingeniería de la película lagrimal, centrándose en la restauración de sus propiedades reológicas para mejorar la lubricación, estabilidad y salud de la superficie ocular. Además, la invención se posiciona dentro del ámbito de las formulaciones oftálmicas de liberación controlada, con tecnologías que optimizan la tensión superficial, la osmolaridad y la viscosidad, proporcionando una solución terapéutica más eficaz y duradera.[French]
La présente invention s'inscrit dans le secteur de l'ophtalmologie, spécifiquement, dans le développement de collyres ophtalmologiques avancés. Ce domaine comprend des formulations pharmaceutiques destinées au traitement de maladies oculaires chroniques. La technologie développée combine des approches innovantes dans la tribologie oculaire et la bioingénierie du film lacrymal, se centrant sur la restauration de ses propriétés rhéologiques pour améliorer la lubrification, la stabilité et la santé de la surface oculaire. En outre, l'invention s'inscrit dans le domaine des formulations ophtalmiques à libération contrôlée, avec des technologies qui optimisent la tension superficielle, l'osmolarité et la viscosité, fournissant une solution thérapeutique plus efficace et plus durable.